SCN2A and Epileptic encephalopathy: Subsequently, we and others reported a number of de novo SCN2A mutations in patients with neurological disorders such as epileptic encephalopathy including Ohtahara syndrome, West syndrome, Lennox Gastaut syndrome5–9, ASD10,11, intellectual disability12,13, and schizophrenia14,15.